π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This trial will look at a drug called SEA-TGT (also known as SGN-TGT) to fi...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2020-05-29
Trial ID
NCT04254107
Treatments Being Tested
This study aims to evaluate the safety, and early signals of anti-tumor act...
Status
Terminated
Location
Florida Cancer Specialists Sarasota Drug Development Unit
Start Date
2024-02-08
Trial ID
NCT06285097
Treatments Being Tested
This is a Phase 1b/2 protocol to evaluate pharmacokinetics, safety, efficac...
Status
Completed
Location
Beijing Cancer hospital
Start Date
2020-03-18
Trial ID
NCT04181788
Treatments Being Tested
The purpose of this study is to learn about the safety and effects of the s...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2024-12-10
Trial ID
NCT06704724
The purpose of this study is to learn how a new medicine called PF-08052667...
Status
Recruiting
Location
The Kirklin Clinic of UAB Hospital
Start Date
2025-11-06
Trial ID
NCT07206225
Treatments Being Tested
This is a first-in-human, Phase 1, open label, multicenter, multiple dose, ...
Status
Terminated
Location
City of Hope
Start Date
2021-10-20
Trial ID
NCT05061537
Treatments Being Tested
Phase 1b/Phase 2 Umbrella Study; open-label, multi-center, parallel group s...
Status
Terminated
Location
City of Hope Investigational Drug Services (IDS)
Start Date
2020-11-10
Trial ID
NCT04585815
Treatments Being Tested
This study investigates whether a single subcutaneous administration of ant...
Status
Not Yet Recruiting
Location
Eberhard Karls Universitaet Tuebingen (EKUT)
Start Date
2025-02
Trial ID
NCT06218069
Treatments Being Tested
The primary objective of this study is to evaluate the safety, tolerability...
Status
Withdrawn
Location
Columbia University Medical Center - Herbert Irving Pavilion
Start Date
2022-03-24
Trial ID
NCT05259397
Treatments Being Tested
The purpose of this study is to assess the safety and effects of PF-0726502...
Status
Terminated
Location
HonorHealth Research Institute
Start Date
2022-02-24
Trial ID
NCT05233436
Treatments Being Tested